Ultragenyx Pharmaceutical, Inc. (RARE)
21.25
-0.21
(-0.98%)
USD |
NASDAQ |
Mar 06, 16:00
22.00
+0.75
(+3.53%)
After-Hours: 20:00
Ultragenyx Pharmaceutical SG&A Expense (TTM) : 350.06M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 448.72M |
| Johnson & Johnson | 23.68B |
| CorMedix, Inc. | 60.19M |
| BioMarin Pharmaceutical, Inc. | 1.153B |
| Insmed, Inc. | 701.17M |